GSK, pushing back UTI filing by a year, shows antibiotic's gonorrhea potential in phase 3
GSK may have pushed back plans to secure approval for gepotidacin as the first new urinary tract infection (UTI) treatment in 20 years, but fresh phase 3 results have lined up the antibiotic for a...